Inscription Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.41M | Buy |
26,514
+2,164
| +9% | +$253K | 0.3% | 57 |
|
|
2026
Q1 | $2.93M | Buy |
24,350
+409
| +2% | +$47.2K | 0.31% | 56 |
|
|
2025
Q4 | $2.52M | Sell |
23,941
-539
| -2% | -$50.6K | 0.26% | 57 |
|
|
2025
Q3 | $2.05M | Buy |
24,480
+700
| +3% | +$57.7K | 0.22% | 68 |
|
|
2025
Q2 | $1.88M | Sell |
23,780
-13,867
| -37% | -$1.1M | 0.27% | 65 |
|
|
2025
Q1 | $4.97M | Buy |
+37,647
| New | +$3.51M | 0.82% | 24 |
|
|
2024
Q3 | $4.03M | Sell |
35,496
-1,646
| -4% | -$196K | 0.6% | 30 |
|
|
2024
Q2 | $4.6M | Sell |
37,142
-505
| -1% | -$65K | 0.74% | 25 |
|
|
2024
Q1 | $4.97M | Buy |
37,647
+6,808
| +22% | +$839K | 0.82% | 24 |
|
|
2023
Q4 | $3.36M | Buy |
30,839
+1,922
| +7% | +$200K | 0.92% | 21 |
|
|
2023
Q3 | $2.98M | Sell |
28,917
-50
| -0.2% | -$5.39K | 0.97% | 20 |
|
|
2023
Q2 | $3.34M | Sell |
28,967
-768
| -3% | -$87.2K | 1.04% | 21 |
|
|
2023
Q1 | $3.16M | Buy |
29,735
+103
| +0.3% | +$11.1K | 0.84% | 24 |
|
|
2022
Q4 | $3.29M | Sell |
29,632
-205
| -0.7% | -$21K | 1.12% | 17 |
|
|
2022
Q3 | $2.57M | Sell |
29,837
-137,405
| -82% | -$12.3M | 0.73% | 25 |
|
|
2022
Q2 | $15.2M | Buy |
167,242
+136,760
| +449% | +$12.1M | 2.75% | 6 |
|
|
2022
Q1 | $2.52M | Sell |
30,482
-1,700
| -5% | -$134K | 0.72% | 34 |
|
|
2021
Q4 | $2.49M | Buy |
32,182
+2,601
| +9% | +$207K | 0.68% | 37 |
|
|
2021
Q3 | $2.24M | Sell |
29,581
-53,170
| -64% | -$4.04M | 0.7% | 39 |
|
|
2021
Q2 | $6.44M | Buy |
82,751
+52,690
| +175% | +$3.92M | 0.73% | 26 |
|
|
2021
Q1 | $2.23M | Sell |
30,061
-3,150
| -9% | -$232K | 0.76% | 38 |
|
|
2020
Q4 | $2.61M | Buy |
33,211
+2,087
| +7% | +$160K | 1.01% | 25 |
|
|
2020
Q3 | $2.48M | Sell |
31,124
-499
| -2% | -$39.1K | 1.1% | 20 |
|
|
2020
Q2 | $2.35M | Buy |
31,623
+3,521
| +13% | +$265K | 1.3% | 16 |
|
|
2020
Q1 | $2.08M | Sell |
28,102
-471
| -2% | -$37K | 1.38% | 17 |
|
|
2019
Q4 | $2.5M | Buy |
28,573
+7,576
| +36% | +$622K | 1.11% | 19 |
|
|
2019
Q3 | $1.7M | Buy |
+20,997
| New | +$1.68M | 0.93% | 25 |
|
|
2019
Q2 | – | Sell |
-892
| Closed | -$71K | – | 195 |
|
|
2019
Q1 | $71K | Sell |
892
-540
| -38% | -$40.4K | 0.04% | 178 |
|
|
2018
Q4 | $105K | Buy |
+1,432
| New | +$101K | 0.06% | 158 |
|
Other funds holding MRK
Inscription Capital's MRK Position: Q2 2026 in Review
Inscription Capital increased its Merck (MRK) stake by 8.9% in Q2 2026, buying an estimated $253K and bringing the position to 26,514 shares worth $3.41M. The position accounts for 0.3% of the portfolio, ranked #57.
Inscription Capital first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $15.2M in Q2 2022. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Inscription Capital held 26,514 shares of Merck worth $3.41M as of Q2 2026.
- Inscription Capital bought 2,164 Merck shares in Q2 2026, an estimated $253K.
- Merck made up 0.3% of Inscription Capital's portfolio in Q2 2026, its #57 holding.
- Inscription Capital first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
- Inscription Capital's Merck position peaked at $15.2M in Q2 2022.
- 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.